Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Net Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-390.98M
↓ 46% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-267.10M
Historical baseline
PeriodValueYoY Change
TTM$-390.98M-5.1%
2024$-372.18M+16.2%
2023$-444.04M-12.2%
2022$-395.89M-15.7%
2021$-342.25M-31.8%
2020$-259.58M-31.4%
2019$-197.56M-59.9%
2018$-123.58M-34.2%
2017$-92.06M-74.1%
2016$-52.89M-